Probiotic Effect on Gastrointestinal Symptoms (FLORABIOTIC REFUERZO).

Status Recruiting

Clinical Trial Summary

The goal of this randomized clinical trial is to evaluate the effect on the microbiota and the reduction in the number and/or intensity of symptoms of gastrointestinal discomfort of consuming a probiotic or placebo for 6 weeks in adult women and men. The main questions to answer are: 1. To study changes in the alpha diversity of the microbiota. 2. To evaluate changes in the salivary cortisol. For this purpose, a randomized, double blind crossover study has been designed. Target sample size is 30 subjects. Participants will be allocated in two groups for 16 weeks (6 weeks consuming one of the products + 4 weeks wash-out period + 6 weeks consuming the other product). - Group 1 (n=15): 6 weeks daily consumption of one probiotic capsule + 4 weeks wash-out period+ 6 weeks daily consumption of one placebo capsule. - Group 2 (n=15): 6 weeks daily consumption of one placebo capsule + 4 weeks wash-out period+ 6 weeks daily consumption of one probiotic capsule.

Clinical Trial Description

Volunteers who wish to participate in the study will be interviewed by phone to verify that they meet the main inclusion criteria. Volunteers who meet the main inclusion criteria will be invited to an information and screening visit to resolve any doubts. Volunteers who agree to participate in the study will sign the informed consent and will be randomly allocated to one of the two arms of the study and will be provided with any required material. During the intervention, volunteers will attend 4 visits distributed in two phases of 6 weeks separated by 4 weeks of wash-out period. At the beginning and at the end of each phase there will be a clinical visit. In all visits anthropometric and body composition measurements, stool and saliva samples, as well as data about dietary and physical activity will be collected. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06248177
Study type	Interventional
Source	Clinica Universidad de Navarra, Universidad de Navarra
Contact	Fermín Milagro Yoldi
Phone	+34948425600
Email	fmilagro@unav.es
Status	Recruiting
Phase	N/A
Start date	January 16, 2024
Completion date	July 30, 2024

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT03239197` - Project SHARE (motherS Have All the Right microbEs)	N/A
Completed	`NCT04117802` - Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome	N/A
Recruiting	`NCT05941663` - Microbiome Development in the Early Healing of Osseointegrated Implants	N/A
Recruiting	`NCT06144905` - Norwegian Microbiota Study in Anorexia Nervosa
Active, not recruiting	`NCT05864352` - The Role of Dietary Titanium Dioxide on the Human Gut Microbiome and Health
Recruiting	`NCT04138979` - Intestinal Microbiota of Breast Cancer Patients Undergoing Chemotherapy
Recruiting	`NCT04132713` - Study on Skin Microbiome of HFS
Completed	`NCT05726435` - Effects of Soluble Dietary Fiber on Sport Efficiency and Fatigue Delay in Top Basketball Players	N/A
Recruiting	`NCT02695784` - Probiotics After Discharge	Phase 4
Completed	`NCT03543891` - Intestinal Microbiota and Thyroid Cancer
Completed	`NCT05242913` - Effects of Resistant Potato Starch on the Gut Microbiota	N/A
Recruiting	`NCT04200521` - The Effect of Bariatric Procedures on Gut Microbiota in Obese Individuals in United Arab Emirates and Lebanon
Recruiting	`NCT05891977` - Effect of Tomato Paste Consumption on the Microbiota-gut-brain Axis in Healthy Adults	N/A
Completed	`NCT02988349` - Ecological Effect of Arginine Dentifrice on Oral Microbiota	N/A
Completed	`NCT05352724` - Clinical Trial to Evaluate the Efficacy of a Sport Drink After High-intensity Aerobic Exercise	N/A
Completed	`NCT04674839` - The Impact of MS-20 on Gut Microbiota Composition in Adult Individuals	N/A
Completed	`NCT03754504` - Effects of Cranberry Powder Supplements on Gut Microbiota Diversity and Metabolic Syndrome	N/A
Completed	`NCT05394948` - Circular Economy and the Design of Healthy and Sustainable Food and Ingredients	N/A
Terminated	`NCT03752372` - Microbiome Alterations in IL10RA-deficient Patients After HSCT
Completed	`NCT05974124` - Effectiveness of Ophthalmic Antiseptic Preparations	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Probiotic Effect on Gastrointestinal Symptoms (FLORABIOTIC REFUERZO). — FLORABIOTIC

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms